Scientific Advisory Board

Christoph Lengauer, PhD MBA

Third Rock Ventures

Ronald T. Borchardt

Distinguished Professor Emeritus of Pharmaceutical Chemistry,
The University of Kansas-Lawrence

Howard A. “Skip” Burris III, MD, FASCO, FACP

President & Chief Medical Officer, Sarah Cannon;
Associate, Tennessee Oncology, PLLC

Ron Eydelloth, DVM DACVP

Nonclinical Development Consulting Services

Peter Kiener, PhD

Chief Executive Officer,
Cereius Inc.

Peter Smith

Chief Early Development Officer,
Alnylam Pharmaceuticals

K. Dane Wittrup, PhD

Professor of Chemical Engineering and Biological Engineering, MIT;
Associate Director, Koch Institute